Page last updated: 2024-10-30

mefenamic acid and Blood Coagulation Disorders

mefenamic acid has been researched along with Blood Coagulation Disorders in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fraser, IS1
McCarron, G1
Markham, R1
Resta, T1
Watts, A1

Other Studies

1 other study available for mefenamic acid and Blood Coagulation Disorders

ArticleYear
Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.
    Obstetrics and gynecology, 1986, Volume: 68, Issue:5

    Topics: Blood Coagulation Disorders; Endometriosis; Female; Humans; Mefenamic Acid; Menorrhagia; Menstruatio

1986